Comparison of Three Different Chemotherapy Regimens Containing Epirubicin in Hormone-Refractory Prostate Cancer Patients

We compared three different chemotherapy regimens containing epirubicin in hormonerefractory prostate cancer (HRPC) patients. Sixty-nine patients with HRPC were randomized into three groups. The first group (22 patients) received 30 mg/m(2)/week i.v. epirubicin for 8 weeks. The second group (24 pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ScientificWorldJournal
Hauptverfasser: Ersoy, Hamit, Yigitbası, Orhan, Sagnak, Levent, Topaloglu, Hikmet, Kiper, Ahmet
Format: Artigo
Sprache:Inglês
Veröffentlicht: TheScientificWorldJOURNAL 2008
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848728/
https://ncbi.nlm.nih.gov/pubmed/18604442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2008.90
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge